36 research outputs found

    Nouvelles règles, nouveaux défis : Les mutuelles au cœur de la construction d’un marché de l’assurance complémentaire santé.

    No full text
    Les réformes de la protection sociale en santé mises en œuvre depuis les années 1990 ont non seulement modifié le financement mais également conduit à une délégation d’une partie de la régulation de l’offre de soins aux Organismes complémentaires d’assurance maladie (OCAM). Les pouvoirs publics ont adopté différents dispositifs : loi Le Roux, contrats responsables, généralisation de la complémentaire d’entreprises et 100 % santé qui, en visant à solvabiliser le marché, ont permis de le développer les OCAM et d’en faire des acteurs à part entière du système de protection sociale. L’objet de ce travail est d’analyser ces dispositifs à travers une grille de lecture fondée sur trois formes d’injonctions : financière, politique et/ou sociale. L’article pointe à la fois la continuité et les incohérences de ces dispositifs, notamment leur capacité à générer des inégalités sociales nouvelles dans le champ de l’assurance complémentaire santé

    Developing innovative drugs through the commons Lessons from the DNDi experience

    No full text
    In this paper we argue that DNDi, even though it belongs to the family of Product Development Partnerships (PDPs) created at the end of the 20th century, has followed a very particular trajectory, that allows us to characterize it as a distinctive commons in the field of public health. We illustrate this view by focusing on two features: DNDi’s promotion of collaborative platforms and its innovative intellectual property policy

    La santé, un business ?

    No full text
    International audienc

    Les services publics au Royaume-Uni et en France face aux politiques d'austérité

    No full text
    After the 2007-2008 financial crisis, most developed countries first massively supported their banking systems before putting in place various policies for economic reflation. While avoiding the worst, these interventions often led to a sharp increase in fiscal deficits. In 2010, these Keynesian-inspired policies gave way to various measures of fiscal consolidation, particularly in European countries. These have had a greater or lesser impact on public services. The aim of this volume is first to examine the differences and similarities of public service systems in two major European countries, the United Kingdom and France, and to study the policies of fiscal consolidation they have put in place since 2010. Can the concept of "austerity" actually embrace seemingly different public policies, some of which have reinforced neo-liberalism and new public management, while others are more in keeping with more traditional policies of controlling public spending ? It is then necessary to analyse the effects of these "austerity" policies on public services and users in the two countries, both in terms of services, organization and delegation of public service functions to the private sector

    Les transformations de l’assurance maladie complémentaire à la lumière de la démutualisation/hybridation des banques coopératives

    Get PDF
    International audienceThis paper sets out to assess the evolution of two comparable sectors: third sector banks on the one hand, and health insurance and provident societies on the other hand. While the former embarked on consolidation and partial privatization—at the expense of mutualization—as early as the 1980s, the latter are currently undergoing a similar but more cautious evolution. The present paper starts with a comparative analysis of the two sectors and goes on to show that the hybridization processes witnessed in banking are not paralleled in the area of supplementary health insurance. Hybridization processes certainly run counter to the mutualized activities of third sector banks. However, mutual insurance and provident societies are more faithful to their founding principles.Ce travail analyse l’évolution de deux secteurs comparables : les banques mutualistes et coopératives (M&C) d’une part, les mutuelles de santé et les institutions de prévoyance d’autre part. Si les premières ont entamé une phase de concentration du capital et de démutualisation/hybridation dès les années 1980, les secondes connaissent aujourd’hui une évolution semblable, mais plus prudente. L’article propose dans un premier temps une analyse comparative des deux secteurs et montre dans une seconde partie que les processus d’hybridation constatés dans le secteur bancaire ne sont pas identiques dans l’assurance maladie complémentaire. Les processus de démutualisation/hybridation n’ont pas été sans conséquence sur le fonctionnement des banques M&C, mais il semble que les mutuelles de santé et les institutions de prévoyance protègent mieux leurs principes mutualistes originels

    The Impact on Big Pharma’s Production Model of Medicine Policies in a Context of Austerity in France and the UK

    No full text
    The austerity policies implemented by France and the United Kingdom since the 2008 crisis have led to a drastic rationalisation of health spending in both countries. This is especially true for spending on medicines, which is an important part of the health budget. Even though health policies in the two countries seem to be very different, given the specificities of each health system, this rationalisation has expressed itself through greater privatisation, a hardening of mechanisms for controlling the prices of the most expensive drugs and incentives to use the cheapest drugs when possible, such as generic drugs. The pharmaceutical industry has not suffered much from these measures. It first reacted, at least provisionally, by accepting to develop generic drugs. As of 2012, Big Pharma companies have started to implement a new model for producing innovation and highly expensive drugs, grounded in biotechnology and customised medicine. This strategy is based on highly outsourced industrial organisations which have allowed the industry to benefit from healthcare systems, to reduce risks and to make large profits
    corecore